BioProtocol (BIO) fluctuates 42.5% in 24 hours: EliLilly acquisition news and whale purchases drive rebound
Bitget Pulse2026/04/30 07:46Volatility Overview
In the past 24 hours, the price of BIO rebounded from a low of $0.03204 to a high of $0.04565, with the current quote at $0.0455, marking an overall amplitude of 42.5%. The 24-hour trading volume surged significantly to approximately $179 million, a sharp increase from usual levels, indicating heightened capital activity.
Brief Analysis of Market Movements
- Eli Lilly's acquisition of Crossbridge Bio (a VitaDAO derivative project) triggered BIO to become one of the day's hot coins, driving a price rebound and pushing it to the top of the trending list.
- A whale opened a $602k long position on Hyperliquid, combined with the upcoming Peptide TGE (Token Generation Event) and a staking priority mechanism, stimulating short-term buying interest.
- Technically, the price broke above the 8-hour descending wedge upper boundary, accompanied by increased trading volume, forming a series of higher highs.
Market Views and Outlook
The mainstream sentiment within the community is bullish, with several traders considering it “this week’s free long opportunity,” predicting further movement toward $0.0435-$0.056, but emphasize not to chase highs and to wait for pullbacks to enter, while warning against potential FOMO traps in the evening. Analysts point out the rebound potential at $0.045, but note that attention should be paid to the sustainability of the DeSci sector's valuation.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Treasury "Extreme Short Sellers" Gather! With Oil Prices and Treasury Yields "Dual Pressure," Rate Hike Expectations Surge, Market Bets Real Money on a New Round of Tightening
According to some veteran Wall Street analysts, the most favorable combination for the market is a small rate hike accompanied by a clear data-dependent stance, allowing investors to interpret it as a limited and moderate monetary policy adjustment to guard against recurring inflation.
Intel CEO: CPU only meets 50% of demand, 14A to start production in Q1 next year, new architecture may reduce inference power consumption to 1/15 of GPU
Intel CEO Pat Gelsinger stated that the era of AI agents has triggered an explosion in CPU demand, and Intel is currently able to meet only about 50% of its customers' supply needs, with several tech giant CEOs calling to secure supply. In terms of manufacturing process, the 18A node is now in full mass production, while the 14A node will begin production in the first quarter of next year. By opening up factory data, yield rates are improving by about 7% annually. Additionally, he is advancing neuromorphic computing to address energy consumption bottlenecks and expects quantum computing to have a substantial industrial impact within 3 to 5 years.
